18-160
Showing 26 - 50 of >10,000
Papillomavirus Infections Trial in Worldwide (9vHPV Vaccine, Placebo (Saline for Injection))
Active, not recruiting
- Papillomavirus Infections
- 9vHPV Vaccine
- Placebo (Saline for Injection)
-
Northridge, California
- +102 more
Aug 17, 2022
Sustained Threat in Adolescents With Depression
Not yet recruiting
- Depression in Adolescence
- Trier Social Stress Test (TSST)
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Jan 13, 2023
Computed Tomography Angiography, Coronary Artery Disease Trial in Sohag (Coronary computed tomography angiography)
Recruiting
- Computed Tomography Angiography
- Coronary Artery Disease
- Coronary computed tomography angiography
-
Sohag, EgyptSohag University hospitals
Feb 6, 2023
Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC, efgartigimod IV)
Completed
- Generalized Myasthenia Gravis
- efgartigimod PH20 SC
- efgartigimod IV
-
Carlsbad, California
- +46 more
Jan 31, 2022
NSCLC, NSCLC Trial in Australia, Austria, United States (AMG 160)
Recruiting
- Non-small Cell Lung Cancer
- NSCLC
- AMG 160
-
Houston, Texas
- +3 more
Mar 29, 2022
Breast Cancer, Nurse, Education Trial in Mersin (Reminder message)
Recruiting
- Breast Cancer
- +4 more
- Reminder message
-
Mersin, TurkeyGamze Bozkul
Aug 25, 2023
Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113, Placebo)
Completed
- Generalized Myasthenia Gravis
- ARGX-113
- Placebo
-
Phoenix, Arizona
- +65 more
Jan 14, 2022
HIV Trial in Saint Louis (gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- gp160 Vaccine (MicroGeneSys)
-
Saint Louis, MissouriSt. Louis Univ. School of Medicine AVEG
Oct 27, 2021
Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open
Not yet recruiting
- Systemic Sclerosis
- Scleroderma
- Anifrolumab (blinded)
- +2 more
-
Birmingham, Alabama
- +130 more
Jun 22, 2023
Knee Osteoarthritis Trial (Triamcinolone, Platelet Rich Plasma)
Not yet recruiting
- Knee Osteoarthritis
- Triamcinolone
- Platelet Rich Plasma
- (no location specified)
Sep 6, 2023
Tuberculosis Trial in Chendu (BCG vaccine 1(0.025mg/0.1ml/person), BCG vaccine 2 (0.05mg/0.1ml/person), BCG vaccine
Recruiting
- Tuberculosis
- BCG vaccine 1(0.025mg/0.1ml/person)
- +4 more
-
Chendu, Sichuan, ChinaSichuan Center for Disease Control and Prevention
Sep 1, 2022
Moderate and Severe Rheumatoid Arthritis Trial in Shanghai (Placebo plus MTX, RC18 160 mg plus MTX)
Terminated
- Moderate and Severe Rheumatoid Arthritis
- Placebo plus MTX
- RC18 160 mg plus MTX
-
Shanghai, Shanghai, ChinaRenji Hospital Shanghai Jiaotong University School of Medicine
Apr 1, 2019
Active Psoriatic Arthritis Trial in Worldwide (TILD, matching injections)
Recruiting
- Active Psoriatic Arthritis
- TILD
- matching placebo injections
-
Anniston, Alabama
- +98 more
Nov 25, 2022
Insomnia Chronic, Pain, Chronic Trial in Surrey (Clonidine pill)
Completed
- Insomnia Chronic
- Pain, Chronic
- Clonidine 0.1mg pill
- +3 more
-
Surrey, British Columbia, CanadaSalem Anaesthesia Pain Clinic
Nov 15, 2022
Breast Cancer, HER2-positive Breast Cancer Trial in Toronto (Neratinib)
Not yet recruiting
- Breast Cancer
- HER2-positive Breast Cancer
-
Toronto, Ontario, CanadaUniversity Health Network: Princess Margaret Cancer Centre
Oct 31, 2022
Epilepsy Trial in Reggio Calabria (Rapid withdrawal of antiepileptic, Slow withdrawal of antiepileptic)
Completed
- Epilepsy
- Rapid withdrawal of antiepileptic
- Slow withdrawal of antiepileptic
-
Reggio Calabria, ItalyRegional Epilepsy Center, Presidio Riuniti, Magna Græcia Univers
Feb 1, 2022
Education, Patient Trial in Izmir (Video-assisted training)
Active, not recruiting
- Education, Patient
- Video-assisted training
-
İzmir, Menemen, Turkeyizmir Bakircay University
Jun 21, 2023
Heart Failure, Essential Hypertension Trial in Moscow (LCZ 696, Valsartan)
Recruiting
- Heart Failure
- Essential Hypertension
- LCZ 696
- Valsartan
-
Moscow, Russian FederationNational Medical Research Center for Cardiology
Jan 10, 2022
Ulcerative Colitis Trial in Worldwide (CP-690,500 5 mg, CP-690,550 10 mg)
Terminated
- Ulcerative Colitis
- CP-690,500 5 mg
- CP-690,550 10 mg
-
Mobile, Alabama
- +79 more
Aug 3, 2022
Alzheimer Trial in Paris (Detailed ophthalmologic examination)
Recruiting
- Alzheimer Disease
- Detailed ophthalmologic examination
-
Paris, FranceCentre Mémoire de Ressources et de Recherche Paris Nord
Oct 11, 2022
Coccidioidomycosis Trial in San Antonio (Placebo, VT-1598)
Completed
- Coccidioidomycosis
- Placebo
- VT-1598
-
San Antonio, TexasICON Early Phase Services Clinical Research Unit
Dec 15, 2022